Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany
- 1 January 2000
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (1) , 37-52
Abstract
Objective: To use published data to compare the economic consequences of specific immunotherapy (SIT) lasting 3 years with those of continuous symptomatic treatment in patients with either pollen or...Keywords
This publication has 41 references indexed in Scilit:
- The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in GermanyPharmacoEconomics, 1998
- The Use of Consensus Methods and Expert Panels in Pharmacoeconomic StudiesPharmacoEconomics, 1997
- A Cost-Utility Analysis of Second-Line Chemotherapy in Metastatic Breast CancerPharmacoEconomics, 1996
- Economic Outcomes for the Treatment of Allergic RhinitisPharmacoEconomics, 1996
- Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug TherapiesPharmacoEconomics, 1992
- Cost-of-Illness StudiesPharmacoEconomics, 1992
- The Cost of MigrainePharmacoEconomics, 1992
- Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extractJournal of Allergy and Clinical Immunology, 1990
- Specific IgE response toward allergenic molecules during perennial hyposensitization: a three year prospective double-blind studyJournal of Allergy and Clinical Immunology, 1983
- Controlled evaluation of allergoid in the immunotherapy of ragweed hay feverJournal of Allergy and Clinical Immunology, 1982